The word “palliative” can make a useful conversation harder before it has even begun. It is often heard as a signal that treatment is ending. In reality, palliative care can be an additional layer of support while cancer treatment continues. That distinction is worth making early, when there is time to address symptoms, uncertainty, and the practical strain of living with illness.
Evidence at a glance
Population: the clearest trials discussed here involve advanced non–small-cell lung cancer. Intervention: regular specialist palliative-care visits integrated with oncology. Meaningful outcome: better quality of life in an early trial; a later study found similar quality of life with video and in-person delivery. This is supportive care, not a replacement for anticancer treatment.
What the early trial actually showed
A 2010 randomized trial enrolled 151 patients with newly diagnosed metastatic non–small-cell lung cancer. Participants received either standard oncology care alone or oncology plus early palliative care. At 12 weeks, average FACT-L quality-of-life scores were 98.0 versus 91.5, favoring the additional support—a 6.5-point difference. Depressive symptoms were also less common: 16% versus 38%.
Median survival was 11.6 versus 8.9 months. That finding attracted attention, but survival was not the primary endpoint. This was a relatively small, single-center study, conducted in an earlier treatment era, and some patients died before follow-up assessments. It does not establish that palliative care directly controls tumors or promises a particular survival gain for another cancer. The central clinical point is that additional symptom and decision support can improve the experience of care.
Could some of that support happen by video?
The 2024 REACH PC trial randomized 1,250 patients with advanced non–small-cell lung cancer at 22 US centers to video-based or in-person early palliative care. Visits were planned every four weeks. Importantly, the video group began with an in-person visit; this was not a completely remote service from day one.
At 24 weeks, FACT-L scores were 99.7 with video and 97.7 in person. The difference met the trial’s prespecified equivalence criterion. But caregiver participation was lower during video delivery: 36.6% versus 49.7%. Convenience does not automatically mean that everyone who needs to be in the conversation is included. Both groups received palliative care, so this trial compares delivery methods, not palliative care against no support. Findings in lung cancer also cannot establish equivalence for every diagnosis or clinical situation.
What palliative care is—and is not
The 2024 ASCO guideline recommends early specialist palliative care alongside active treatment for advanced solid tumors and hematologic malignancies. It is a team-based service, not a single drug, supplement, or fixed prescription. The appropriate frequency and mix of symptom management, communication, and caregiver support depend on the person.
As the National Cancer Institute explains, palliative care can be provided throughout the cancer experience. Hospice is a different care framework. Accepting help with pain, breathlessness, emotional distress, or difficult decisions does not itself mean declining cancer treatment.
Practical safety still matters. The oncology and palliative teams should share medication lists and clarify who manages side effects such as sedation or constipation. A scheduled supportive-care visit is not a reason to wait on urgent symptoms: follow the oncology team’s instructions for fever, sudden breathlessness, or rapidly worsening illness. My takeaway is simple: support should be organized around need, not postponed because of what a label seems to imply.
Questions for the care team
- Could a palliative-care consultation help now while my cancer treatment continues?
- Which symptoms and daily activities should we prioritize?
- Would video visits work for me, and when is an in-person assessment needed?
- How can we include my caregiver and coordinate medication changes between teams?
Evidence checked October 15, 2026. Educational review; research doses and schedules are not personal prescriptions. Explore the Missing Script article library and the podcast—coming soon.
